Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
150,442Documents
1,450Full text
2026-09-23Last indexed
Recent documents from this source
- Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis#253004
- PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer#253003
- Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma#253002
- Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia#253001
- PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer#253000
- A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors#252999
- Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie#252998
- Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment#252997
- Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning#252996
- A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer#252995
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial#252994
- CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma#252993
- Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction#252992
- Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer#252991
- ARID1A and/or KDM6A Mutation and CXCL13 Expression#252990
- Study of Immunotherapy to Treat Advanced Prostate Cancer#252989
- Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies#252988
- Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma#252987
- Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma#252986
- Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC#252985
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).